Abstract
Interstitial lung disease (ILD) affects up to 40% of patients with systemic sclerosis (SSc) and is the leading cause of death.1 The risk of ILD is increased in SSc patients...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
